Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data
暂无分享,去创建一个
F. Guillemin | C. Louapre | B. Brochet | N. Moore | E. Bignon | R. Lassalle | P. Blin | M. Debouverie | O. Heinzlef | E. Maillart | M. Soulié | S. Le Moulec | J. Jové | M. Roumiguié | A. Abouelfath | P. Bosco-Lévy | M. Rouyer | S. Lignot | N. Thurin | S. Lamarque | P. Diez | C. Droz‐Perroteau | M. Gross‐Goupil | M. Soulie
[1] C. Louapre,et al. Comparative effectiveness of dimethyl fumarate in multiple sclerosis , 2021, British journal of clinical pharmacology.
[2] N. Moore,et al. Epidemiology of metastatic castration-resistant prostate cancer: A first estimate of incidence and prevalence using the French nationwide healthcare database. , 2020, Cancer epidemiology.
[3] N. Moore,et al. Survival outcome in patients with metastatic castration-resistant prostate cancer according to first-line treatment. , 2020 .
[4] P. Tubert-Bitter,et al. Validation study: evaluation of the metrological quality of French hospital data for perinatal algorithms , 2020, BMJ Open.
[5] Rosa Gini,et al. Disease misclassification in electronic healthcare database studies: Deriving validity indices—A contribution from the ADVANCE project , 2020, PloS one.
[6] E. Oger,et al. French administrative health care database (SNDS): The value of its enrichment. , 2019, Therapie.
[7] M. Goldberg,et al. Identifying diabetes cases in health administrative databases: a validation study based on a large French cohort , 2018, International Journal of Public Health.
[8] G. Chatellier,et al. Diagnostic accuracy of the International Classification of Diseases, Tenth Revision, codes of heart failure in an administrative database , 2018, Pharmacoepidemiology and drug safety.
[9] M. Kulldorff,et al. Reuse of data sources to evaluate drug safety signals: When is it appropriate? , 2018, Pharmacoepidemiology and drug safety.
[10] M. Lapeyre-Mestre,et al. Positive predictive values of peripheral arterial and venous thrombosis codes in French hospital database , 2018, Fundamental & clinical pharmacology.
[11] G. Hindricks,et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.
[12] J. Coste,et al. Value of a national administrative database to guide public decisions: From the système national d'information interrégimes de l'Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France. , 2017, Revue d'epidemiologie et de sante publique.
[13] David Madigan,et al. Good practices for real‐world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR‐ISPE Special Task Force on real‐world evidence in health care decision making , 2017, Pharmacoepidemiology and drug safety.
[14] Nicholas Moore,et al. The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology , 2017, Pharmacoepidemiology and drug safety.
[15] D. Cohen,et al. Publisher's Note , 2017, Neuroscience & Biobehavioral Reviews.
[16] M. Lapeyre-Mestre,et al. Identifying multiple myeloma patients using data from the French health insurance databases , 2017, Medicine.
[17] Valérie Lanneau,et al. Clinical Practice Guidelines for Rare Diseases: The Orphanet Database , 2017, PloS one.
[18] M. Lapeyre-Mestre,et al. Validation of an algorithm identifying incident primary immune thrombocytopenia in the French national health insurance database , 2016, European journal of haematology.
[19] A. Bruandet,et al. Création d’un outil de gestion des contrôles qualités du codage au DIM du CHRU de Lille , 2016 .
[20] Kevin Haynes,et al. Identifying health outcomes in healthcare databases , 2015, Pharmacoepidemiology and drug safety.
[21] M. Hommel,et al. Positive Predictive Value of French Hospitalization Discharge Codes for Stroke and Transient Ischemic Attack , 2015, European Neurology.
[22] Andrea C. Skelly,et al. Administrative Database Studies: Goldmine or Goose Chase? , 2014, Evidence-Based Spine-Care Journal.
[23] Michael Friger,et al. Use of administrative medical databases in population-based research , 2013, Journal of Epidemiology & Community Health.
[24] B. Strom. What Is Pharmacoepidemiology? , 2013, Pharmacoepidemiology.
[25] F. Hartmann,et al. Sources of financial pressure and up coding behavior in French public hospitals. , 2013, Health policy.
[26] I. Baldi,et al. Évaluation des performances du PMSI pour l’identification des tumeurs incidentes du système nerveux central par rapport à un registre spécialisé en Gironde, France, en 2004 , 2012 .
[27] P. Little,et al. Guideline for the management of acute sore throat. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[28] R. Carnahan,et al. Mini‐Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative and claims data: methods and lessons learned , 2012, Pharmacoepidemiology and drug safety.
[29] R. Carnahan,et al. Mini‐Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative data: summary of findings and suggestions for future research , 2012, Pharmacoepidemiology and drug safety.
[30] Carl van Walraven,et al. Administrative database research infrequently used validated diagnostic or procedural codes. , 2011, Journal of clinical epidemiology.
[31] C. Marescaux. Entre soin et contrôle de gestion : place du DIM dans l'organisation hospitalière , 2011, L'information psychiatrique.
[32] W. Ray,et al. Improving Automated Database Studies , 2011, Epidemiology.
[33] Ø. Lidegaard. Epidemiologic research using administrative databases: garbage in, garbage out. , 2011, Obstetrics and gynecology.
[34] K. Devers,et al. Health services research and data linkages: issues, methods, and directions for the future. , 2010, Health services research.
[35] A. Walker. Orthogonal predictions: follow‐up questions for suggestive data , 2010, Pharmacoepidemiology and drug safety.
[36] A. Gould. Generating and confirming hypotheses , 2010, Pharmacoepidemiology and drug safety.
[37] Sean Hennessy,et al. Use of health care databases in pharmacoepidemiology. , 2006, Basic & clinical pharmacology & toxicology.